Cosciens Biopharma (AEZS) has called a special shareholder meeting for June 17, 2026, at 9:30 a.m. ET.
In an SEC filing, the company announced that shareholders received a notice and proxy form. The meeting will cover items in the Management Proxy Circular.
CFO Giuliano La Fratta signed the filing. The Toronto-based firm was formerly Aeterna Zentaris.
Stay tuned to Bond.az for more updates.












